Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
Clinical trial NCT01858883 · COMPLETED
Trial details
- NCT number
- NCT01858883
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-02-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.